<DOC>
	<DOCNO>NCT02455908</DOCNO>
	<brief_summary>The aim study design open-label phase 1-2 trial ass safety clinical immunologic effect repeat administration recombinant low dose IL2 ( Proleukin ) 5 patient idiopathic nephrotic syndrome unresponsive drug ( steroid , calcineurin inhibitor , Rituximab ) , follow therapeutical scheme indicate crioglobulinemic nephropathy : cycle1 : IL2 1x106 /m2 s.c 5 consecutive day cycle2 : IL2 1.5 x106 / m2 s.c 5 consecutive day , start 3 week first cycle . cycle3 : IL2 1.5 x106 /m2 s.c 5 consecutive day , start 6 week first cycle . Cycle 4 : IL2 1.5 x106 /m2 s.c 5 consecutive day , start 9 week first cycle . Current therapy steroid calcineurin inhibitor ( Prograf ) maintain first cycle progressively reduce subsequent cycle . The first cycle perform hospitalization investigator Unit ; subsequent cycle perform nephrology outpatient . All laboratory value normally utilized follow patient affect idiopathic nephrotic syndrome evaluate first week treatment end protocol , together specific cellular value ( Tregs , B cell , NK ) .</brief_summary>
	<brief_title>IL-2 Multi Drug Resistant Nephrotic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Nephrotic Syndrome</mesh_term>
	<mesh_term>Nephrosis</mesh_term>
	<mesh_term>Aldesleukin</mesh_term>
	<criteria>Drug resistance : persistence proteinuria nephrotic range cycle steroid least 3 month association cyclosporine/tacrolimus least 6 month Parents'/guardian 's write informed consent , child 's assent give studyrelated procedure part subject 's normal medical care , understand consent may withdraw subject time without prejudice future medical care . Age 2 18 year Histological pattern minimal change disease , mesangial proliferation IgM deposit focal segmental glomerulosclerosis Positivity autoimmunity test ( ANA , dsDNA , ANCA ) . Reduction C3 level . Hystological pattern characterize element suggestive congenital disease : diffuse mesangial sclerosis without IgM deposit , cysticlike tubular dilatation , mitochondrial abnormality evident electron microscopy , IF suggestive congenital collagen 4 disease . Histological pattern suitable INS pediatric age ( membranous glomerulonephritis , lupus nephritis , diffuse and/or localize vasculitis , amyloidosis ) Homozygous heterozygous mutation 3 gene ( NPHS1 , NPHS2 , WT1 ) whose mutation know responsible almost 80 % familiar case</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>